JPRN-UMIN000040759已完成未知
Mechanism of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) among lung cancer patients with EGFR mutant - Mechanism of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) among lung cancer patients with EGFR mutant
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who excluded from clinical trials
研究者
相似试验
已完成
不适用
The effects of epidermal growth factor receptor inhibition on pulmonary arterial hypertension associated with systemic sclerosisSclerosis-associated Pulmonary Arterial Hypertension (SScPAH)Circulatory SystemPulmonary Arterial HypertensionISRCTN75611179VU University Medical Centre (The Netherlands)20
已完成
2 期
EGFpeeling IAcne scarring, melasm, or other injuries that require chemical peeling.RPCEC00000107Center for Genetic Engineering and Biotechnology (CIGB), in Havana.30
撤回
2 期
The Effects of Epidermal Growth Factor Receptor (EGFR) Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis A phase II controlled open-label safety and efficacy study.high pulmonary vascular pressure associated with scleroderma100192801001076110037454NL-OMON30491Vrije Universiteit Medisch Centrum20
已完成
2 期
The effectiveness of an epidermal growth factor containing cream on postinflammatory hyperpigmentation after 1064 nm Q-switched Nd:YAG laser treatment of Hori nevus in AsiansPostinflammatory hyperpigmentationParticipants with symmetrical Hori nevusEpidermal growth factor1,064-nm Q-switched Nd:YAG laserHori nevusTCTR20210301001Division of Dermatology Ramathibodi hospital30
已完成
1 期
A Phase 1 Study of Epidermal Growth Factor Receptor (EGFR) Targeted, PaclitaxelLoaded EnGeneIC Delivery Vehicles (Erbitux®EDVsPac) in Patients with Advanced SolidTumoursAdvanced Solid TumoursCancer - Other cancer typesACTRN12609000672257EnGeneIC Pty Ltd32